Level Bio AB (publ) 4MB.F Stock
Level Bio AB (publ) Price Chart
Level Bio AB (publ) 4MB.F Financial and Trading Overview
| Level Bio AB (publ) stock price | 0.02 EUR |
| Previous Close | 0.05 EUR |
| Open | 0.05 EUR |
| Bid | 0.05 EUR x N/A |
| Ask | 0.07 EUR x N/A |
| Day's Range | 0.05 - 0.05 EUR |
| 52 Week Range | 0.02 - 0.08 EUR |
| Volume | 800 EUR |
| Avg. Volume | 0 EUR |
| Market Cap | 3.9M EUR |
| Beta (5Y Monthly) | 0.170881 |
| PE Ratio (TTM) | Infinity |
| EPS (TTM) | -0.01 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
4MB.F Valuation Measures
| Enterprise Value | 3.21M EUR |
| Trailing P/E | Infinity |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.54022986 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Level Bio AB (publ) Stock Price History
| Beta (5Y Monthly) | 0.170881 |
| 52-Week Change | -14.52% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.08 EUR |
| 52 Week Low | 0.02 EUR |
| 50-Day Moving Average | 0.04 EUR |
| 200-Day Moving Average | 0.04 EUR |
4MB.F Share Statistics
| Avg. Volume (3 month) | 0 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 63.19M |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | 0% |
| % Held by Institutions | 0.029% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -14.011% |
| Operating Margin (ttm) | 0% |
| Gross Margin | -6.33% |
| EBITDA Margin | -7.27% |
Management Effectiveness
| Return on Assets (ttm) | -9.40% |
| Return on Equity (ttm) | -19.59% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | -35.89% |
| Gross Profit (ttm) | 15.25M EUR |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | 0 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 3.202 |
| Book Value Per Share (mrq) | 0.087 |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Profile of Level Bio AB (publ)
| Country | Germany |
| State | N/A |
| City | Stockholm |
| Address | Västra Finnbodavägen 4B |
| ZIP | 131 30 |
| Phone | 46 86 26 76 00 |
| Website | https://www.alphahelix.com |
| Industry | Diagnostics & Research |
| Sector(s) | Healthcare |
| Full Time Employees | 13 |
AlphaHelix Molecular Diagnostics AB (publ) develops, manufactures, and sells products for PCR/QPCR applications. It also operates as a supplier and partner for clinical laboratories and research laboratories in the Nordic region. The company provides smarter reagents, consumables, and instruments for customers in research and diagnostics. Its product portfolio includes Rob, an automated 96/384 qPCR setup; BugScreener, a methicillin-resistant staphylococcus aureus extraction system; and aAmp, a thermal cycler that utilizes SuperConvection technology that enables accurate PCR assays. The company was incorporated in 1998 and is headquartered in Stockholm, Sweden.
Q&A For Level Bio AB (publ) Stock
What is a current 4MB.F stock price?
Level Bio AB (publ) 4MB.F stock price today per share is 0.02 EUR.
How to purchase Level Bio AB (publ) stock?
You can buy 4MB.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Level Bio AB (publ)?
The stock symbol or ticker of Level Bio AB (publ) is 4MB.F.
Which industry does the Level Bio AB (publ) company belong to?
The Level Bio AB (publ) industry is Diagnostics & Research.
How many shares does Level Bio AB (publ) have in circulation?
The max supply of Level Bio AB (publ) shares is 105.18M.
What is Level Bio AB (publ) Price to Earnings Ratio (PE Ratio)?
Level Bio AB (publ) PE Ratio is now.
What was Level Bio AB (publ) earnings per share over the trailing 12 months (TTM)?
Level Bio AB (publ) EPS is -0.01 EUR over the trailing 12 months.
Which sector does the Level Bio AB (publ) company belong to?
The Level Bio AB (publ) sector is Healthcare.